The Use of Mitoxantrone Plus Cyclophosphamide as First-line Treament of Metastatic Breast Cancer

The Use of Mitoxantrone Plus Cyclophosphamide as First-line Treament of Metastatic Breast Cancer[J]. Cancer Research on Prevention and Treatment, 1987, 14(2): 128-128.

Citation:

The Use of Mitoxantrone Plus Cyclophosphamide as First-line Treament of Metastatic Breast Cancer[J]. Cancer Research on Prevention and Treatment, 1987, 14(2): 128-128.

Citation:

The Use of Mitoxantrone Plus Cyclophosphamide as First-line Treament of Metastatic Breast Cancer[J]. Cancer Research on Prevention and Treatment, 1987, 14(2): 128-128.

The Use of Mitoxantrone Plus Cyclophosphamide as First-line Treament of Metastatic Breast Cancer

Graphical Abstract

Graphical Abstract

Abstract

Abstract

Thirty-two patients with metastatic breast cancer who had not received prior chemotherapy for metastatic disease were entered into a trial of mitoxantrone 12mg/m² plus cyclophos phamide 600mg/m² given at three weelky intervals.

FullText(HTML)

References (0)

Cited By

Turn off MathJax

Article Contents

The Use of Mitoxantrone Plus Cyclophosphamide as First-line Treament of Metastatic Breast Cancer

Graphical Abstract

Abstract

Catalog

Export File

Citation

Format

Content